Drug Type Small molecule drug |
Synonyms 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide |
Target |
Action inhibitors |
Mechanism galectin-3 inhibitors(Galectin-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Preclinical | China | 01 Dec 2025 |





